Exit

Stanford-backed Eero connects to Amazon
Stanford-backed wifi system developer Eero has been picked up by Amazon after launching a product designed to provide high performance for devices including smart home products.
Marinomed hits Vienna Stock Exchange
VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.
Ansys grabs Cambridge spinout Granta
Engineering and 3D design product firm Ansys has bought Cambridge-founded Granta Design and will offer the company's materials information products to its customers.
Samsung trains its focus on Corephotonics
Samsung is reportedly eyeing Tel Aviv University-founded smartphone camera technology developer Corephotonics for $150m to $160m after backing its series B and C rounds.
Mahle puts ZG into gear
Founded out of TUM, transmission gear manufacturer ZG-Zahnräder und Getriebe has been bought by Mahle to bolster its integrated drive system capacity.
OraSure carries up CoreBiome
Minnesota-founded microbial analysis spinout CoreBiome has been bought by medical diagnostics firm OraSure Technology after raising $1.4m from investors including Minnesota’s Discovery Capital fund.
Boston Scientific picks up Millipede for $325m
Boston Scientific has exercised its option to wholly acquire Millipede, based on research at Michigan, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.
Lighthouse AI loses spark
StartX-backed Lighthouse AI failed to garner enough commercial interest in its interactive household camera despite raising $17m in funding.

Other News

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Moderna loads up $604m in IPO
Investors including co-founder and Harvard professor Timothy Springer scored exits as mRNA therapy developer Moderna floated in the largest biotech IPO of all time.
10X Genomics picks up Spatial Transcriptomics
10X Genomics has purchased genomic analysis platform Spatial Transcriptomics, based on research at Karolinska Institute and KTH Royal Institute of Technology.
Chief auditor queries WIT exit
Ireland’s Comptroller and Auditor General has highlighted issues in a Waterford Institute of Technology licensing deal that garnered low returns when the spinout in question was acquired.
Synthorx to synthesise $100m IPO
Synthorx, spun out of Scripps Research Institute, is targeting $100m in a proposed offering half a year after it raised $63m in a series C round backed by Osage University Partners.
Marinomed makes its way to stock exchange
The biopharmaceutical spinout of University of Veterinary Medicine Vienna is issuing 400,000 shares in an initial public offering that is set to fetch between $34m and $41m.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Nucana and Nightstar race to public markets
Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.
test reg

Login